2019
DOI: 10.1016/j.matpr.2019.04.051
|View full text |Cite
|
Sign up to set email alerts
|

Setting Properties of Calcium Phosphate Bone Cement

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(11 citation statements)
references
References 9 publications
0
10
0
Order By: Relevance
“…A critical difference of CPC from PMMA is that CPC is progressively resorbed by osteoblasts over days to weeks, resulting in new bone, whereas PMMA is inert and will inevitably lead to a fibrous layer between itself and bone, never to be replaced with bone [19]. While the prospect of a biologically viable "cement" is exciting, unfortunately no CPC formulation is currently approved for weight-bearing situations [20].…”
Section: Discussionmentioning
confidence: 99%
“…A critical difference of CPC from PMMA is that CPC is progressively resorbed by osteoblasts over days to weeks, resulting in new bone, whereas PMMA is inert and will inevitably lead to a fibrous layer between itself and bone, never to be replaced with bone [19]. While the prospect of a biologically viable "cement" is exciting, unfortunately no CPC formulation is currently approved for weight-bearing situations [20].…”
Section: Discussionmentioning
confidence: 99%
“…Despite a thermodynamically metastable species relative to HA, DCPD (also called brushite) has been widely applied to pathological calcifications and gentle polishing agents in toothpastes. DCPD is also an important component of bone cement in bone repair due to its faster resorption than apatite. , Recently, a new CaP cement with a Ca/P ratio of 1.38, consisting of the mixed components of α-tricalcium phosphate, HA, and DCPD, was produced by the rapid addition of solution Ca­(NO 3 ) 2 ·4H 2 O to the stirring solution (NH 4 ) 2 HPO 4 with pH = 4.5–5 at room temperature . DCPD could be easily crystallized in acid solutions (pH = 2.0–6.0) from aqueous solutions containing soluble calcium salts (Ca­(NO 3 ) 2 ·4H 2 O, CaCl 2 ·2H 2 O, or Ca­(CH 3 COO) 2 ·H 2 O) and phosphate salts (NH 4 H 2 PO 4 , (NH 4 ) 2 HPO 4 , Na 2 HPO 4 , NaH 2 PO 4 , KH 2 PO 4 , or K 2 HPO 4 ) ,, at room temperature and a Ca/P ratio of 1.00.…”
Section: Introductionmentioning
confidence: 99%
“…32,33 Recently, a new CaP cement with a Ca/P ratio of 1.38, consisting of the mixed components of α-tricalcium phosphate, HA, and DCPD, was produced by the rapid addition of solution Ca(NO 3 ) 2 •4H 2 O to the stirring solution (NH 4 ) 2 HPO 4 with pH = 4.5−5 at room temperature. 32 DCPD could be easily crystallized in acid solutions (pH = 2.0−6.0) 4 from aqueous solutions containing soluble calcium salts (Ca(NO 3 ) 8,15,34−37 at room temperature and a Ca/P ratio of 1.00. The morphology of DCPD changed with additives, initial pH values, and ion concentrations.…”
Section: Introductionmentioning
confidence: 99%
“…Inorganic CPCs often have critical drawbacks that limit their possible clinical application, including a lack of injectability [ 12 , 13 ] that is generally characterized by phase separation during injection, low mechanical properties for the loading requirements of the implantation site [ 14 , 15 ] as well as a weak cohesion that results in the disintegration of the cement paste when in contact with physiological fluids [ 2 , 13 ].…”
Section: Introductionmentioning
confidence: 99%